Ongoing Studies

Acne Scar Study
(Venus Concept, 32 Weeks)

Sadick Research Group is conducting a clinical study of adult females and males receiving fractional radiofrequency treatment for acne scarring.

Study Details

Phase: Post-Market
Gender: Male and Female
Minimum Age: 21 Years Old
Maximum Age: N/A
Facility Type: Outpatient
Stipend Range: Up to $150 Upon Study Completion
Study Length: 6 Months
Sponsor: Venus Concept

Study Description

This is an evaluator-blind study of the safety and performance of fractional radiofrequency for the treatment and reduction of acne scarring. All enrolled subjects will receive 3 treatments to the face, with 3-5 week intervals between treatments. There are 6 in-office visits throughout the study and can include a physical exam, urine sampling, photographs, subject assessments, and assessments by qualified professionals. All services are provided at no cost.

Inclusion and Exclusion Criteria

Eligible female and male participants will be over the age of 21 and seeking treatment and reduction of their acne scarring. Subjects with a history of immunosuppressive diseases, history of any type of cancer, history of diseases stimulated by heat, and poorly controlled endocrine disorders will not be eligible for participation. Females cannot plan to become pregnant or be breast feeding for the duration of the study. Subjects must be available for 6 study visits and willing to comply with all study instructions. Several other restrictions and criteria may apply that the study doctor will review with you to determine if you qualify for this study.

Other Trial Details

  • No insurance necessary.
  • Compensation will be provided at the end of study participation. 

PARTICIPATE IN THIS STUDY

Acne Scarring Study (Venus Concept, 32 Weeks)






Contact Information

Interested in our research? Join our newsletter

Send us a message

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt
Acne StudyFacial Wrinkles